Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
GO Krill Oil 750 mg Odourless, The Better Health Company (Australia) PTY, CON-260
Product name
GO Krill Oil 750 mg Odourless
Sponsor name
The Better Health Company (Australia) PTY
ARTG
292073
Consent start
Consent no.
CON-260
Standard
The United States Pharmacopeia-National Formulary (USP41-NF36) monograph for Krill Oil, the default standard for Krill Oil in Australia.
Non-compliance with standard
The content of palmitoleic acid exceeds the upper specification level by 0.16%.
(Current USP41-NF36 specifications for palmitoleic acid are 2.5% to 9.0%).
Conditions imposed
1. The content of palmitoleic to be within the specifications of 2.5% to
12.0%.
2. The raw material in relation to which the consent is given must comply
with all other applicable parts of the USP41-NF36 and all other applicable
standards.
Therapeutic product type
Listed complementary medicines